Prosecution Insights
Last updated: October 04, 2026

Cytonus Therapeutics Inc.

1 pending office actions • 0 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready

Analysis

Cytonus Therapeutics Inc. currently has 1 pending office action in its patent portfolio. This matter is assigned to a distinct examiner, although the data indicates 0 distinct art units are currently associated with the pending workload. This active office action represents the entirety of the company's current interaction with the patent office. The focus on an individual examiner suggests a specific prosecution path at this stage.

The busiest examiner for this portfolio is GONZALES, JOSEPHINE MARIA, who is managing 1 busiest examiner pending office action. Because GONZALES, JOSEPHINE MARIA is the sole examiner responsible for the company's active docket, the prosecution strategy can be entirely customized to the preferences of this individual. The presence of 0 distinct art units simplifies the administrative oversight required for these patent filings. This concentration of review allows for a direct and focused response strategy.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
1
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (100%)
0
Medium (0%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
Multi-statute (no §101)1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

0
Life Sciences
0% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
1
Business / Other
100% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
GONZALES, JOSEPHINE MARIA 1 26.6% +38.4%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18632925 SYSTEMS AND METHODS FOR MANUFACTURING OF THERAPEUTIC CELLS GONZALES, JOSEPHINE MARIA —

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18632925 SYSTEMS AND METHODS FOR MANUFACTURING OF THERAPEUTIC CELLS GONZALES, JOSEPHINE MARIA —

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18632925 SYSTEMS AND METHODS FOR MANUFACTURING OF THERAPEUTIC CELLS GONZALES, JOSEPHINE MARIA — §102§103§112 Non-Final OA — Pending Apr 11, 2024

Managing Cytonus Therapeutics Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month